Toronto-Dominion Bank »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2026-03-31 $984k 953k 1.03

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cibc Cad (CM)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Canadian Natural Resources (CNQ)
Apple (AAPL)
Bk Nova Cad (BNS)
Amazon (AMZN)
Suncor Energy (SU)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Silver Tr Ishares (SLV)
Bank Of Montreal Cadcom (BMO)

View all positions for Toronto-Dominion Bank

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Linden Advisors
Camden Asset Management
LMR Partners
Readystate Asset Management
Calamos Advisors
Jump Financial
Context Capital Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Oaktree Capital Management
Polar Securities
Lazard Asset Management
Shenkman Capital Management
Point72 Asset Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1